| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.15 | 4e-06 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.14 | 1e-05 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.13 | 2e-05 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.32 | 2e-05 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-05 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.14 | 5e-05 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.13 | 9e-05 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.12 | 9e-05 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0001 |